Angina, UnstableMyocardial InfarctionAngina PectorisCoronary AngiographyElectrocardiographyAngioplasty, Balloon, CoronaryInfarctionAngina Pectoris, VariantTime FactorsProspective StudiesThrombolytic TherapyTreatment OutcomeRisk FactorsCoronary DiseaseAngina, StableCerebral InfarctionMyocardial IschemiaPlatelet Aggregation InhibitorsCreatine KinaseMyocardial RevascularizationCoronary ThrombosisCoronary Artery DiseaseFollow-Up StudiesPrognosisCoronary VesselsAnterior Wall Myocardial InfarctionRecurrenceAcute Coronary SyndromeCoronary Care UnitsChest PainMyocardial ReperfusionCoronary Artery BypassFibrinolytic AgentsPredictive Value of TestsTroponin TVentricular RemodelingAcute DiseaseStreptokinaseBiological MarkersAtherectomy, CoronaryStentsAspirinMyocardiumRisk AssessmentVentricular Function, LeftRetrospective StudiesCoronary CirculationPercutaneous Coronary InterventionPlatelet Glycoprotein GPIIb-IIIa ComplexHospital MortalityHeparinHirudin TherapyElectrocardiography, AmbulatoryHemorrhageEchocardiographyDouble-Blind MethodExercise TestMicrovascular AnginaCoronary VasospasmStroke VolumeAnticoagulantsProportional Hazards ModelsTroponin ISyndromeC-Reactive ProteinHospitalizationRegistriesIncidenceVentricular Dysfunction, LeftCardiac CatheterizationSurvival AnalysisMultivariate AnalysisHeartCoronary StenosisEnoxaparinAdrenergic beta-AntagonistsCardiovascular AgentsShock, CardiogenicTroponinCohort StudiesHeart FailureCreatine Kinase, MB FormRiskInferior Wall Myocardial InfarctionDeath, Sudden, CardiacTiclopidineCase-Control StudiesChi-Square DistributionStrokeArrhythmias, CardiacTissue Plasminogen ActivatorImmunoglobulin Fab FragmentsDrug-Eluting StentsHirudinsSurvival RateLogistic ModelsCardiovascular DiseasesFibrinopeptide ADrug Therapy, CombinationIsosorbide Dinitrate